USPH Stock Analysis: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$77.75
0.01 (0.01%)
â˛
5d:
+0.56%
30d:
-0.08%
90d:
+24.4%
WAIT
LOW Confidence
Analysis Updated: Sep 1, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At -0.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: USPH is fairly priced but lacks strong directional signals. At -0.4% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$129.00
Based on 10.5% avg growth
INTRINSIC VALUE TODAY
$80.10
2.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $77.75, which is considered slightly low relative to its 30-day fair value range of $77.15 to $80.64. The stock's valuation (Forward PE: 23.0) is in line with its historical norms (23.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, USPH is in a uptrend. The price is currently testing key support at $76.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $95.00 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, USPH is in a uptrend. The price is currently testing key support at $76.43. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $95.00 (+22.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$77.15 -
$80.64
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.2% below Wall St target ($95.00)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$77.15 -
$80.64
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$76.43
Resistance Level
$80.66
Current Trend
Uptrend
Technical data as of
Sep 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.99
Wall Street Target
$95.00
(+22.2%)
Revenue Growth (YoY)
8.5%
Earnings Growth (YoY)
-56.5%
Profit Margin
4.0%
Valuation Discount vs History
-0.4% cheaper
PE vs Historical
23.0 vs 23.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.4%
(market-implied from PE analysis)
1-Year Target
$77.44
(0%)
2-Year Target
$77.13
(-1%)
3-Year Target
$76.82
(-1%)
3-Yr Target (if PE normalizes)
(PE: 23â23)
$77.87
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 16.9%)
$124.20
(+60%)
Base:
(SPY PE: 20.1, Growth: 16.9%)
$108.61
(+40%)
Bear:
(PE: 17.1, Growth: 16.9%)
$92.32
(+19%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 28.74 | Forward EPS (Implied): $2.71
Bull Case
$93.88
(+21%)
Analyst growth 15.0%, PE expands to 30.2
Base Case
$77.75
(0%)
Market implied 0.0%, PE stable at 28.7
Bear Case
$59.48
(-24%)
Severe decline -15.0%, PE contracts to 25.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.0 to 23.3
Stabilization Target:
$78.81
(+1.4%)
PE Expansion Potential:
+1.4%
Share & Embed Analysis
Last updated: September 02, 2026 8:39 AM ET
Data refreshes hourly during market hours. Next update: 9:39 AM
Data refreshes hourly during market hours. Next update: 9:39 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Graham D Reeve
SELL
662 shares
2026-03-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$282 | 45 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 44 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 52 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 45 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 49 HOLD |
